Probing conformational changes in the estrogen receptor: Evidence for a partially unfolded intermediate facilitating ligand binding and release

Molecular Endocrinology

Volumn 15, Issue 3, 2001, Pages 421-428

  Gee, A C ^a   Katzenellenbogen, J A ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIS ANILINONAPTHALENESULFONATE; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GUANIDINE; HORMONE RECEPTOR; SULFONIC ACID DERIVATIVE; TRYPTOPHAN; UNCLASSIFIED DRUG;

ARTICLE; CONFORMATION; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; FLUORESCENCE; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN DENATURATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN MOTIF; PROTEIN STABILITY; PROTEIN STRUCTURE;

EID: 0035102591     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.15.3.0602     Document Type: Article

References (43)

1. Nuclear hormone receptors: Ligand-activated regulators of transcription and diverse cell responses
2. Molecular basis of agonism and antagonism in the oestrogen receptor
3. Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid
4. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
5. A structural role for hormone in the thyroid hormone receptor
6. Structure and specificity of nuclear receptor-coactivator interactions
7. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors
8. A signature motif in transcriptional co-activators mediates binding to nuclear receptors
9. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ
10. Altered ligand binding properties and enhanced stability of a constitutively active estrogen receptor: Evidence that an open pocket conformation is required for ligand interaction
11. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor
12. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α
13. Detection and characterization of an ovine placental lactogen stable intermediate in the urea-induced unfolding process
14. Molecular characterization of α-lactalbumin folding variants that induce apoptosis in tumor cells
15. Apoflavodoxin (un)folding followed at the residue level by NMR
16. The equilibrium unfolding of azobacter vinelandii apoflavodoxin II occurs via a relatively stable folding intermediate
17. Characterization of folded, intermediate, and unfolded states of recombinant human interstitial collagenase
18. Donor-acceptor tetrahydrochrysenes, inherently fluorescent, high-affinity ligands for the estrogen receptor: Binding and fluorescence characteristics and fluorometric assay of receptor
19. 5,6,11,12-Tetrahydrochrysenes: Synthesis of rigid stilbene systems designed to be fluorescent ligands for the estrogen receptor
20. Studies using fluorescent tetrahydrochrysene estrogens for in situ visualization of the estrogen receptor in living cells
21. Interactive intermediates are formed during the urea unfolding of rhodanese
22. Evidence for a molten globule state as a general intermediate in protein folding
23. Study of the "molten globule" intermediate state in protein folding by a hydrophobic fluorescent probe
24. Multiphase denaturation of the λ repressor by urea and its implications for the repressor structure
25. Sequential unfolding of papin in molten globule state
26. Crystal structure of the ligand binding domain of the human nuclear receptor PPARλ
27. Native and non-native secondary structure and dynamics in the pH 4 intermediate of apomyoglobin
28. Molten globular characteristics of the native state of apomyoglobin
29. Protein folding and stability investigated by fluorescence, circular dischroism (CD), and nuclear magnetic resonance (NMR) spectroscopy: The flavodoxin story
30. Ligand-induced stabilization of PPARγ monitored by NMR spectroscopy: Implications for nuclear receptor activation
31. Conformational changes in the human estrogen receptor observed by (19)F NMR
32. Dynamic stabilization of nuclear receptor ligand binding domains by hormone or corepressor binding
33. Molecular chaperone interactions with steroid receptors: An update
34. Steroid receptor interactions with heat shock protein and immunophilin chaperones
35. Folding of the glucocorticoid receptor by the heat shock protein (hsp) 90-based chaperone machinery. The role of p23 is to stabilize receptor·hsp90 heterocomplexes formed by hsp90·p60·hsp70
36. All of the factors required for assembly of the glucocorticoid receptor into a functional heterocomplex with heat shock protein 90 are preassociated in a self-sufficient protein folding structure, a "foldosome"
37. Statistical thermodynamic linkage between conformational and binding equilibria
38. Intrinsically unstructured proteins: Re-assessing the protein structure-function paradigm
39. ERβ: Identification and characterization of a novel human estrogen receptor
40. Measuring the conformational stability of a protein